BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19708088)

  • 21. Protein homeostasis as a therapeutic target for diseases of protein conformation.
    Calamini B; Morimoto RI
    Curr Top Med Chem; 2012; 12(22):2623-40. PubMed ID: 23339312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteostasis: bad news and good news from the endoplasmic reticulum.
    Noack J; Brambilla Pisoni G; Molinari M
    Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
    Maiti P; Manna J; Veleri S; Frautschy S
    Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulating proteostasis: peptidomimetic inhibitors and activators of protein folding.
    Hatahet F; Ruddock LW
    Curr Pharm Des; 2009; 15(21):2488-507. PubMed ID: 19601846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
    Sinnige T; Yu A; Morimoto RI
    Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics.
    Gandhi J; Antonelli AC; Afridi A; Vatsia S; Joshi G; Romanov V; Murray IVJ; Khan SA
    Rev Neurosci; 2019 May; 30(4):339-358. PubMed ID: 30742586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis.
    van der Woerd WL; Wichers CG; Vestergaard AL; Andersen JP; Paulusma CC; Houwen RH; van de Graaf SF
    J Hepatol; 2016 Jun; 64(6):1339-47. PubMed ID: 26879107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Autophagy-Lysosomal Pathways and Their Emerging Roles in Modulating Proteostasis in Tumors.
    Dong Z; Cui H
    Cells; 2018 Dec; 8(1):. PubMed ID: 30577555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein misfolding in disease and small molecule therapies.
    Gomes CM
    Curr Top Med Chem; 2012; 12(22):2460-9. PubMed ID: 23339300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shaping proteostasis at the cellular, tissue, and organismal level.
    Sala AJ; Bott LC; Morimoto RI
    J Cell Biol; 2017 May; 216(5):1231-1241. PubMed ID: 28400444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress.
    Höhn A; Tramutola A; Cascella R
    Oxid Med Cell Longev; 2020; 2020():5497046. PubMed ID: 32308803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteostasis and Proteotoxicity in the Network Medicine Era.
    Lualdi M; Alberio T; Fasano M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Removing protein aggregates: the role of proteolysis in neurodegeneration.
    Nijholt DA; De Kimpe L; Elfrink HL; Hoozemans JJ; Scheper W
    Curr Med Chem; 2011; 18(16):2459-76. PubMed ID: 21568912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical and biological approaches synergize to ameliorate protein-folding diseases.
    Mu TW; Ong DS; Wang YJ; Balch WE; Yates JR; Segatori L; Kelly JW
    Cell; 2008 Sep; 134(5):769-81. PubMed ID: 18775310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAA+ Protein-Based Technologies to Counter Neurodegenerative Disease.
    March ZM; Mack KL; Shorter J
    Biophys J; 2019 Apr; 116(8):1380-1385. PubMed ID: 30952364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An adaptable standard for protein export from the endoplasmic reticulum.
    Wiseman RL; Powers ET; Buxbaum JN; Kelly JW; Balch WE
    Cell; 2007 Nov; 131(4):809-21. PubMed ID: 18022373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.
    Brandvold KR; Morimoto RI
    J Mol Biol; 2015 Sep; 427(18):2931-47. PubMed ID: 26003923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis.
    Walker AC; Bhargava R; Dove AS; Brust AS; Owji AA; Czyż DM
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.